Dermatology · San Diego, CA
NPI
1194884858
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
4647 Zion Ave
San Diego, CA, 92120
Phone (619) 528-5000
Groups this clinician bills Medicare through
Medicare paid, 2024
$670
15 services
Medicare patients, 2024
11
Average age 72
Drug cost, 2024
$405K
1,464 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Charles H Miller prescribed most often to Medicare patients was Clobetasol Propionate, with 282 prescriptions and refills. In total Charles H Miller wrote 1,464 Medicare prescriptions that cost $405K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-29.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Clobetasol Propionate Generic | 282 | 301 | 150 | $7,852 |
| Triamcinolone Acetonide Generic | 146 | 202 | 84 | $4,209 |
| Imiquimod Generic | 121 | 199 | 69 | $3,842 |
| Tacrolimus Generic | 98 | 115 | 55 | $14K |
| Fluorouracil Generic | 80 | 89 | 62 | $4,190 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 51 | 56 | 26 | $1,786 |
| Calcipotriene Generic | 50 | 50 | 33 | $6,343 |
| Metronidazole Generic | 46 | 52 | 19 | $827 |
| Retin-A Tretinoin | 45 | 59 | 16 | $1,957 |
| Fluocinolone Acetonide Fluocinolone/Shower Cap | 45 | 74 | 32 | $2,202 |
| Valacyclovir Valacyclovir Hcl | 41 | 41 | 14 | $463 |
| Vectical Calcitriol | 41 | 45 | 26 | $8,492 |
| Doxycycline Monohydrate Generic | 40 | 71 | 21 | $1,373 |
| Mupirocin Generic | 37 | 37 | 24 | $399 |
| Ketoconazole Generic | 31 | 46 | 17 | $660 |
Brand drugs: 224 claims; generic drugs: 1,240 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Charles H Miller were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.